Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting No phase listed Observational

Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

ClinicalTrials.gov ID: NCT04202341

Public ClinicalTrials.gov record NCT04202341. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:50 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Long-Term, Observational, Global Registry of Patients With Generalized Myasthenia Gravis Who Have Received Treatment With Complement C5 Inhibition Therapies (C5ITs)

Study identification

NCT ID
NCT04202341
Recruitment status
Recruiting
Study type
Observational
Phase
Not listed
Lead sponsor
Alexion Pharmaceuticals, Inc.
Industry
Enrollment
500 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 1, 2019
Primary completion
Sep 30, 2029
Completion
Sep 30, 2029
Last update posted
Feb 17, 2026

2019 – 2029

United States locations

U.S. sites
32
U.S. states
21
U.S. cities
32
Facility City State ZIP Site status
Clinical Trial Site Birmingham Alabama 35294 Recruiting
Clinical Trial Site Scottsdale Arizona 85251 Recruiting
Clinical Trial Site Fresno California 93710 Recruiting
Clinical Trial Site Orange California 92868 Recruiting
Clinical Trial Site Rancho Mirage California 92270 Recruiting
Clinical Trial Site Sylmar California 91342 Recruiting
Clinical Trial Site Colorado Springs Colorado 80907 Recruiting
Clinical Trial Site Fort Collins Colorado 80528 Recruiting
Clinical Trial Site New Haven Connecticut 06520 Recruiting
Clinical Trial Site Washington D.C. District of Columbia 10010 Recruiting
Clinical Trial Site Clearwater Florida 33761 Recruiting
Clincal Trial Site Gainesville Florida 32608 Recruiting
Clinical Trial Site Jacksonville Florida 32209 Recruiting
Clinical Trial Site Tampa Florida 33612 Recruiting
Clinical Trial Site Augusta Georgia 30912 Recruiting
Clinical Trial Site Iowa City Iowa 52242 Recruiting
Clinical Trial Site Lexington Kentucky 40503 Recruiting
Clinical Trial Site Boston Massachusetts 02215 Recruiting
Clinical Trial Site Lansing Michigan 48824 Recruiting
Clinical Trial Site Columbia Missouri 65212 Recruiting
Clinical Trial Site New Hyde Park New York 11042 Recruiting
Clinical Trial Site Chapel Hill North Carolina 27599 Recruiting
Clinical Trial Site Charlotte North Carolina 28207 Recruiting
Clinical Trial Site Durham North Carolina 27705 Recruiting
Clinical Trial Site Dayton Ohio 45459 Recruiting
Clinical Trial Site Philadelphia Pennsylvania 19104 Recruiting
Clinical Trial Site Chattanooga Tennessee 37403 Recruiting
Clinical Trial Site Knoxville Tennessee 37920 Recruiting
Clinical Trial Site Dallas Texas 75206 Recruiting
Clinical Trial Site Houston Texas 77030 Recruiting
Clinical Trial Site Burlington Vermont 05401 Recruiting
Clinical Trial Site Milwaukee Wisconsin 53215 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 19 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04202341, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 17, 2026 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04202341 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →